Live News EQUITY FLASH L impact Oct 29, 2026, 01:40 PM UTC Actuate Therapeutics CEO Reports $49,999.62 Share Acquisition President, CEO and Director Daniel M. Schmitt reported acquiring $49,999.62 in common shares. ACTU SquawkNews Desk